Gonorrhea Rates: What Denominator Is
Most Appropriate?
I read with interest the paper by Aral, et al, on the dramatic differences that can be produced when computing gonorrhea rates by using various populations at risk.' Although I fully agree with the authors that rates per 1,000 population are gross misrepresentations of the true hazard since the population at risk is overestimated, and that rates using various components of sexual activity and behavior, and disease-specific characteristics, be used, I am surprised that the use of contraception, particularly condoms, was not cited as a significant confounding variable which studies of STD (sexually transmitted diseases) exposure must consider.
The use of condoms, particularly given recent public health efforts to reduce the spread of the HIV (human immunodeficiency virus) has many benefits, including a much-reduced risk for unwanted pregnancy and exposure to and infection by a sexually transmitted disease. In fact, the various corrections applied by the authors (per 1,000 sexually experienced women, per 1,000 sexually active women (three months), per 1,000 sexually active women (one month) and per 1,000 sexually active women (consistent)) as well as the myriad of factors outlined in their discussion are of little concern if the frequency of condom use in a population is high. For example, a very active indi-AJPH January 1989, Vol. 79, No. 1 vidual may be at a much more reduced risk for contracting a sexually transmitted disease than one who is considerably less active if the former individual is involved in encounters where a condom is used consistently whereas the converse is true for the latter individual. interest in our paper' and share his view on the role of condom use in reducing risk of sexually transmitted diseases (STD). Condom use prevents semen deposition and should reduce the risk of transmission of organisms that may be present in semen, e.g., Neisseria gonorrhoeae, Chlamydia trachomatis, hepatitis B virus, and human immunodeficiency virus. A condom will also protect the wearer's partner from an infectious urethral discharge or an infectious lesion on the penile skin.2 To be effective, condoms must be used consistently and correctly, and must remain intact.
Available data on condom use are limited. In 1982, of married women using non-surgical contraception, 24 per cent were using the condom.3 Of sexually active never-married women aged 15 to 19 who were using contraception, 22 per cent were using the condom. Between 1982 and 1987, condom use remained steady among married women, at about 15 per cent, but among the unmarried it increased from 9 to 16 per cent.4 Prevalence of additional condom use for STD prevention is not known. Moreover, the proportion of reported condom use which is consistent and correct is difficult to determine. Nonetheless, an optimal measure of exposure to STD risk should incor-porate preventive behaviors, such as condom use, as well as additional aspects of sexual behavior, such as number and infection status of sexual partners. ception of risk of infection was an important predictor of physicians accepting hepatitis B vaccine. Since dentists may be at even greater risk than physicians for hepatitis B,2 we were interested in factors influencing their acceptance of the vaccine. We noted a similar influence of perceived risk in a September 1987 written survey of 540 dental students and faculty at a western dental school. Of the 505 respondents who had no history of hepatitis B infection, 53 per cent had been vaccinated. Those who perceived that 10 per cent or more of their patient population were at risk for hepatitis were significantly more likely to have taken the vaccine (odds ratio = 1.57; 95% confidence interval = 1.06, 2.32). This was the case among both students (n = 320) and faculty (n = 185), with a stronger effect among the faculty-possibly because many (85%) of the unvaccinated students, especially those in their preclinical years, planned to take the vaccine later in their training.
